YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway

Biochemical Pharmacology

Volumn 66, Issue 2, 2003, Pages 263-271

  Hsu, Hun Kung ^a   Juan, Shu Hui ^b   Ho, Pei Yin ^a   Liang, Yu Chih ^b   Lin, Chien Huang ^a   Teng, Che Ming ^c   Lee, Wen Sen ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cyclic GMP; Cyclin; Endothelial cells; p21; p27; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLINE; DNA; GUANYLATE CYCLASE INHIBITOR; KT 5823; METHYLENE BLUE; PROTEIN P21; PROTEIN P27; THYMIDINE; TRITIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DETERMINATION; DNA SYNTHESIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; TIME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 0038771261     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00244-2     Document Type: Article

References (22)

1. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
2. Folkman J. Clinical applications of research on angiogenesis. N. Engl. J. Med. 235:1995;1757-1763.
3. Ko F.N., Wu C.C., Kuo S.C., Lee F.Y., Teng C.-M. YC-1, a novel activator of platalet guanylate cyclase. Blood. 84:1994;4226-4233.
4. Mulsch A., Bauersachs J., Schafer A., Stasch J.P., Kast R., Busse R. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br. J. Pharmacol. 120:1997;681-689.
5. Wohlfart P., Malinski T., Ruetten H., Schindler U., Linz W., Schoenafinger K., Strobe L.H., Wiemer G. Release of nitric oxide from endothelial cells stimulated by YC-1 an activator of soluble guanylyl cyclase. Br. J. Pharmacol. 128:1999;1316-1322.
6. Wu C.C., Ko F.N., Kuo S.C., Lee F.Y., Teng C.-M. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol. 116:1995;1973-1978.
7. Wegener J.W., Nawrath H. Activation of soluble guanylate cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Br. J. Pharmacol. 122:1997;1523-1529.
8. Friebe A., Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol. 53:1998;123-127.
9. Papapetropoulos A., Garcia-Cardena G., Madri J.A., Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100:1997;3131-3139.
10. Lee W.-S., Harder J.A., Yoshizumi M., Lee M.E., Haber E. Progesterone inhibits arterial smooth muscle cell proliferation. Nat. Med. 3:1997;1005-1008.
11. Jain M., He Q., Lee W.-S., Kashiki S., Foster L.C., Tsai J.C., Lee M.E., Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J. Clin. Invest. 97:1996;596-603.
12. Lin S.Y., Liu J.D., Chang H.C., Yeh S.D., Lin C.-H., Lee W.-S. Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J. Cell Biochem. 84:2002;532-544.
13. Ho Y.S., Wang Y.J., Lin J.K. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol. Carcinogen. 16:1996;20-31.
14. 1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene. 12:1996;1397-1403.
15. Lai K., Wang H., Lee W.-S., Jain M.K., Lee M.E., Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J. Clin. Invest. 98:1996;1560-1567.
16. Lin S.Y., Chang Y.T., Liu J.D., Yu C.H., Ho Y.S., Lee W.-S. Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol. Carcinogen. 32:2001;73-83.
17. Hunter T., Pines J. Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
18. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
19. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
20. Lees E. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7:1995;773-780.
21. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
22. Yu S.M., Ceng Z.J., Guh J.H., Lee F.Y., Kuo S.C. Mechanism of antiproliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells. Biochem. J. 306:1995;787-792.